Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Rosen Insider Profile
4 Followers
Robert Rosen, President, Director at Heron Therapeutics, holds 2.64K shares in Heron Therapeutics (Ticker: HRTX), holds ― shares in Odonate Therapeutics (Ticker: ODT), holds 0.00 shares in La Jolla Pharma (Ticker: LJPC).
Robert Rosen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Rosen holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Rosen
Robert Rosen's Trading History
Heron Therapeutics
Jul 03, 2018
President, Director
Uninformative Sell
8.77M
$47.49K
Odonate Therapeutics
―
Director
―
―
La Jolla Pharma
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Robert Rosen's performance on stock
You May Also Like
Robert Rosen insider profile FAQ
What is the percentage of profitable transactions made by Robert Rosen?
The percentage of profitable transactions made by Robert Rosen is ―.
What is the average return per transaction made by Robert Rosen?
The average return per transaction made by Robert Rosen is ―.
What stocks does Robert Rosen hold?
Robert Rosen holds: HRTX, ODT, LJPC stocks.
What was Robert Rosen’s latest transaction?
Robert Rosen latest transaction was an Uninformative Sell of $8.77M.
What was Robert Rosen's most profitable transaction?
Robert Rosen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Rosen's role in Heron Therapeutics?
Robert Rosen's role in Heron Therapeutics is President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.